vTv Therapeutics (VTVT) Free Cash Flow (2014 - 2026)

vTv Therapeutics has disclosed Free Cash Flow across 13 years of filings, most recently posting $9.2 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at $9.2 million, up 260.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.4 million (up 55.98% YoY), and the FY2025 annual result was -$25.3 million, changed 0.21% from the prior year.
• Free Cash Flow came in at $9.2 million for Q1 2026 at vTv Therapeutics, up from -$9.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $9.2 million in Q1 2026 to a low of -$9.3 million in Q4 2025.
• The 5-year median for Free Cash Flow is -$5.2 million (2025), against an average of -$4.5 million.
• Across the five-year window, Free Cash Flow plunged 973.51% in 2023 and surged 260.96% in 2026, its largest moves.
• vTv Therapeutics' Free Cash Flow stood at -$6.9 million in 2022, then jumped by 57.65% to -$2.9 million in 2023, then sank by 65.58% to -$4.8 million in 2024, then tumbled by 91.73% to -$9.3 million in 2025, then soared by 198.95% to $9.2 million in 2026.
• The last three Free Cash Flow figures came in at $9.2 million (Q1 2026), -$9.3 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.